-
-
Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer
RESEARCH TRIANGLE PARK, NC (June 12, 2025) – Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly and neurologically impaired individuals, today announced that Jeff Welch has been named as Chief Operating Officer. Mr. Welch comes to Dignify with over two decades of diverse business…
-
Bolstering Bowel And Bladder Control With Dignify Therapeutics’ Karl Thor
Source: Drug Delivery Leader
-
Dignify Therapeutics Highlights Clinical Development Plans at the BIO CEO & Investor Conference
Research Triangle Park, NC – February 14, 2025 – Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development plans for its lead assets, DTI-117 and DTI-301, at the BIO CEO & Investor Conference held in New York on February 10-11, 2025. During…
-
Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
Company RESEARCH TRIANGLE PARK, NC (October 22, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program ‘geared towards healthcare companies with a product ready to launch into…

